Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients

[1]  S. Knuutila,et al.  Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion , 2014, European Journal of Human Genetics.

[2]  F. Santorelli,et al.  A Novel SUCLA2 Mutation in a Portuguese Child Associated With “Mild” Methylmalonic Aciduria , 2015, Journal of child neurology.

[3]  H. Andersson,et al.  A SUCLG1 mutation in a patient with mitochondrial DNA depletion and congenital anomalies , 2014, Molecular genetics and metabolism reports.

[4]  H. Venselaar,et al.  A Patient with Complex I Deficiency Caused by a Novel ACAD9 Mutation Not Responding to Riboflavin Treatment. , 2014, JIMD reports.

[5]  Brandy Klotzle,et al.  The novel mutation p.Asp251Asn in the β-subunit of succinate-CoA ligase causes encephalomyopathy and elevated succinylcarnitine , 2013, Journal of Human Genetics.

[6]  I. D. de Coo,et al.  A multi-center comparison of diagnostic methods for the biochemical evaluation of suspected mitochondrial disorders , 2013, Mitochondrion.

[7]  M. Zeviani,et al.  A novel homozygous mutation in SUCLA2 gene identified by exome sequencing , 2012, Molecular genetics and metabolism.

[8]  F. Tort,et al.  Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients. , 2012, Molecular genetics and metabolism.

[9]  K. Vesela,et al.  Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis , 2012, Journal of Inherited Metabolic Disease.

[10]  K. Haginoya,et al.  Neonatal lactic acidosis with methylmalonic aciduria due to novel mutations in the SUCLG1 gene , 2011, Pediatrics International.

[11]  H. Shimada,et al.  Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder. , 2011, Molecular genetics and metabolism.

[12]  C. Richelme,et al.  The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein , 2010, Journal of Medical Genetics.

[13]  H. Waterham,et al.  Succinyl-CoA Ligase Deficiency: A Mitochondrial Hepatoencephalomyopathy , 2010, Pediatric Research.

[14]  A. Munnich,et al.  New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria. , 2010, Mitochondrion.

[15]  L. Pérez-Jurado,et al.  Marked mitochondrial DNA depletion associated with a novel SUCLG1 gene mutation resulting in lethal neonatal acidosis, multi-organ failure, and interrupted aortic arch. , 2010, Mitochondrion.

[16]  M. Schwartz,et al.  Limited diagnostic value of enzyme analysis in patients with mitochondrial tRNA mutations , 2010, Muscle & nerve.

[17]  E. Holme,et al.  A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria , 2010, European Journal of Pediatrics.

[18]  R. Carrozzo,et al.  Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. , 2009, Mitochondrion.

[19]  Robert W. Taylor,et al.  Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy , 2008, Neuromuscular Disorders.

[20]  Morten Duno,et al.  Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. , 2007, American journal of human genetics.

[21]  Simona Lucioli,et al.  SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. , 2007, Brain : a journal of neurology.

[22]  M. Schwartz,et al.  Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. , 2007, Brain : a journal of neurology.

[23]  Robert W. Taylor,et al.  Biochemical assays of respiratory chain complex activity. , 2007, Methods in cell biology.

[24]  G. Uziel,et al.  A scale to monitor progression and treatment of mitochondrial disease in children , 2006, Neuromuscular Disorders.

[25]  D. Lambeth.  Reconsideration of the significance of substrate‐level phosphorylation in the citric acid cycle * , 2006, Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology.

[26]  Maria Bitner-Glindzicz,et al.  Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. , 2005, American journal of human genetics.

[27]  A. Jauch,et al.  MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls , 2005, Neurogenetics.

[28]  M. Zeviani,et al.  Clinical and molecular findings in children with complex I deficiency. , 2004, Biochimica et biophysica acta.

[29]  D. Lambeth,et al.  Expression of Two Succinyl-CoA Synthetases with Different Nucleotide Specificities in Mammalian Tissues* , 2004, Journal of Biological Chemistry.

[30]  D. Turnbull,et al.  Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. , 2001, Methods in cell biology.

[31]  D. Lambeth,et al.  Genetic Evidence for the Expression of ATP- and GTP-specific Succinyl-CoA Synthetases in Multicellular Eucaryotes* , 1998, The Journal of Biological Chemistry.

[32]  E. Holme,et al.  Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations. , 1991, The Journal of pediatrics.